Perdomo-Lara SJ, Buenahora MR, Álvarez E, González-Martínez F, Rebolledo M, Aristizabal FA, et al. Human papilloma virus genotypes in dysplasia and epithelial hyperplasia of oral cavity using the luminex xmap technology. A multicenter study. Med Oral Patol Oral Cir Bucal. 2020 Jan 1;25 (1):e61-70.
doi:10.4317/medoral.23188
http://dx.doi.org/doi:10.4317/medoral.23188
1.
Jemal A, Simard EP, Dorell C, et al. Annual Report to the Nation
on the Status of Cancer, 1975-2009, featuring the burden and
trends in human papillomavirus (HPV)-associated cancers and HPV
vaccination coverage levels. J Natl Cancer Inst.
2013;105:175-201. |
|
|||
|
||||
2.
Grulich AE, JIN F, Conway EL, Stein AN, Hocking J. Cancers
attributable to human papillomavirus infection. Sex Health.
2010;7:244-52. |
|
|||
|
||||
3. Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers - United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2012;61:258-61. |
|
|||
|
||||
4.
Jiang S, Dong Y. Human papillomavirus and oral squamous cell
carcinoma: A review of HPV-positive oral squamous cell carcinoma
and possible strategies for future. Curr Probl Cancer.
2017;41:323-27. |
|
|||
|
||||
5.
de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden
of cancer attributable to HPV by site, country and HPV type. Int J
Cancer.
2017;141:664-70. |
|
|||
|
||||
6.
Hübbers CU, Akgül B. HPV and cancer of the oral cavity.
Virulence.
2015;6:244-8. |
|
|||
|
||||
7.
D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral
sexual behaviors associated with prevalent oral human
papillomavirus infection. J Infect Dis.
2009;199:1263-9. |
|
|||
|
||||
8.
Cook RL, Thompson EL, Kelso NE, et al. Sexual behaviors and other
risk factors for oral human papillomavirus infections in young
women. Sex Transm Dis.
2014;41:486-92. |
|
|||
|
||||
9.
Antonsson A, Cornford M, Perry S, Davis M, Dunne MP, Whiteman DC.
Prevalence and risk factors for oral HPV infection in young
Australians. PLoS One.
2014;9:e91761. |
|
|||
|
||||
10.
Doorbar J. Molecular biology of human papillomavirus infection and
cervical cancer. Clin Sci (Lond). 2006;
110:525-41. |
|
|||
|
||||
11.
Campisi G, Panzarella V, Giuliani M, Lajolo C, Di Fede O,
Falaschini S, et al. Human papillomavirus: its identity and
controversial role in oral oncogenesis, premalignant and malignant
lesions (review). Int J Oncol.
2007;30:813-23. |
|
|||
|
||||
12.
Cheng S, Schmidt-Grimminger DC, Murant T, Broker TR, Chow LT.
Differentiation-dependent up-regulation of the human
papillomavirus E7 gene reactivates cellular DNA replication in
suprabasal differentiated keratinocytes. Genes Dev.
1995;9:2335-49. |
|
|||
|
||||
13.
Izumo T. Oral premalignant lesions: from the pathological
viewpoint. Int J Clin Oncol.
2011;16:15-26. |
|
|||
|
||||
14.
Sarode SC, Sarode GS, Karmarkar S, Tupkari JV. A new
classification for potentially malignant disorders of the oral
cavity. Oral Oncol.
2011;47:920-1. |
|
|||
|
||||
15.
Ramya AS, Majumdar S, Babu TM, Uppala D, Srinivas B, Rao AK.
Expression of Human Papillomavirus DNA and p53 Polymorphisms
through Polymerase Chain Reaction in Normal Mucosa and Oral
Leukoplakia Individuals with Deleterious Oral Habits. Int J Appl
Basic Med Res.
2017;7:134-8. |
|
|||
|
||||
16.
Ma J, Zhang J, Zhang Y, Lv T, Liu J. The Magnitude of the
Association between Human Papillomavirus and Oral Lichen Planus: A
Meta-Analysis. PLoS One.
2016;11:e0161339. |
|
|||
|
||||
17.
Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de
Villiers EM. Classification of papillomaviruses (PVs) based on 189
PV types and proposal of taxonomic amendments. Virology.
2010;401:70-9. |
|
|||
|
||||
18.
Szentirmay Z, Polus K, Tamas L, et al. Human papillomavirus in
head and neck cancer: molecular biology and clinicopathological
correlations. Cancer Metastasis Rev. 2005;
24:19-34. |
|
|||
|
||||
19.
Jayaprakash V, Reid M, Hatton E, et al. Human papillomavirus types
16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a
meta-analysis, 1985-2010. Oral Oncol.
2011;47:1048-54. |
|
|||
|
||||
20.
Syrjänen S, Lodi G, von Bültzingslöwen I, Aliko A, Arduino P,
Campisi G, et al. Human papillomaviruses in oral carcinoma and
oral potentially malignant disorders: a systematic review. Oral
Dis. 2011; 17 Suppl
1:58-72. |
|
|||
|
||||
21.
Hormia M, Willberg J, Ruokonen H, Syrjänen S. Marginal
periodontium as a potential reservoir of human papillomavirus in
oral mucosa. J Periodontol.
2005;76:58-63. |
|
|||
|
||||
22.
Jimenez C, Correnti M, Salma N, Cavazza ME, Perrone M. Detection
of human papillomavirus DNA in benign oral squamous epithelial
lesions in Venezuela. J Oral Pathol Med.
2001;30:385-88. |
|
|||
|
||||
23.
de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H.
Classification of Papillomaviruses. Virology.
2004;324:17-27. |
|
|||
|
||||
24.
Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de
Villiers EM. Classification of papillomaviruses (PVs) based on 189
PV types and proposal of taxonomic amendments. Virology.
2010;401:70-9. |
|
|||
|
||||
25.
Zubach V, Smart G, Ratnam S, Severini A. Novel microsphere-based
method for detection and typing of 46 mucosal human papillomavirus
types. J Clin Microbiol.
2012;50:460-4. |
|
|||
|
||||
26. Álvarez GJ, Álvarez E, Jiménez R, Mosquera Y, Gaviria AM, Garcés A, et al. Reverse smokers's and changes in oral mucosa. Department of Sucre, Colombia. Med Oral Patol Oral Cir Bucal. 2008;13:E1-8. |
|
|||
|
||||
27.
Huang CG, Lee LA, Liao CT, Yen TC, Yang SL, Liu YC, et al.
Molecular and serologic markers of HPV 16 infection are associated
with local recurrence in patients with oral cavity squamous cell
carcinoma. Oncotarget.
2017;8:34820-35. |
|
|||
|
||||
28.
Spector ME, Sacco AG, Bellile E, et al. E6 and E7 Antibody Levels
Are Potential Biomarkers of Recurrence in Patients with
Advanced-Stage Human Papillomavirus-Positive Oropharyngeal
Squamous Cell Carcinoma. Clin Cancer Res.
2017;23:2723-9. |
|
|||
|
||||
29.
Gomez-Armayones S, Chimenos-Küstner E, Marí A, Tous S, Penin R,
Clavero O, et al. Human papillomavirus in premalignant oral
lesions: No evidence of association in a Spanish cohort. PLoS One.
2019;14:e0210070. |
|
|||
|
||||
30.
Nankivell P, Williams H, Webster K, Pearson D, High A, MacLennan
K, Senguven B, McConkey C, Rabbitts P, Mehanna H. Investigation of
p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia.
J Oral Pathol Med.
2014;43:245-9. |
|
|||
|
||||
31. Castellsagué X, Alemany L, Quer M, Halec G, Quirós B, Tous S, et al. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. J Natl Cancer Inst. 2016;108:djv403. |
|
|||
|
||||
32.
Chen X1, Zhao Y2. Human papillomavirus infection in oral
potentially malignant disorders and cancer. Arch Oral Biol.
2017;83:334-9. |
|
|||
|
||||
33.Tam
S, Fu S, Xu L, Krause KJ, et al. The epidemiology of oral human
papillomavirus infection in healthy populations: A systematic
review and meta-analysis. Oral Oncol.
2018;82:91-9. |
|
|||
|
||||
34.
Mohammed KA, Subramaniam DS, Geneus CJ, Henderson ER, Dean CA,
Subramaniam DP, Burroughs TE. Rural-urban differences in human
papillomavirus knowledge and awareness among US adults. Prev Med.
2018;109:39-43. |
|
|||
|
||||
35. Bui TC, Tran LT, Thai TN, Shete SS, Vidrine DJ, Sturgis EM. Prevalence of and Risk Factors for Oral Human Papillomavirus Infection with Multiple Genotypes in the United States. Sex Transm Dis. 2017;44:166-72. |
|
|||
|
||||
36.
Akhondnezhad M, Haghshenas MR, Ghasemi M, Mousavi T. The
prevalence and genotyping of human papillomavirus in patients with
oral tumors in health centers and clinics of Mazandaran in Iran.
Virusdisease.
2018;29:297-302. |
|
|||
|
||||
37.
Anantharaman D, Abedi-Ardekani B, Beachler DC, Gheit T, Olshan AF,
Wisniewski K, et al,. Geographic heterogeneity in the prevalence
of human papillomavirus in head and neck cancer. Int J Cancer.
2017;140:1968-75. |
|
|||
|
||||
38.
Gomez-Armayones S, Chimenos-Küstner E, Marí A, Tous S, Penin R,
Clavero O et al. Human papillomavirus in premalignant oral
lesions: No evidence of association in a Spanishcohort. PLoS One.
2019;14:e0210070. |
|
|||
|
||||